Merck’s Covid Pill Is Authorized for High-Risk Adults | New York Times

CEID Founding Director Dr. Nahid Bhadelia discusses the role of the newly-authorized COVID-19 pill from Merck. “’Anything that keeps people out of the hospital, even incremental, has a role,’ said Dr. Nahid Bhadelia, director of the Center for Emerging Infectious Diseases Policy and Research at Boston University.” Read the full article here

NFL could become trend-setter for COVID-19 testing policies | Associated Press

CEID Faculty Dr. David Hamer shared his thoughts on the NFL’s response to the omicron variant. “’The other side is that they’re going to have more players that are out there that are infected that are potentially transmitting to other players and leading to a greater burden of infections,’ said Dr. David Hamer, professor of […]

Omicron Takes Over as Dominant Strain in Mass. | NBC 10 Boston

CEID Faculty Dr. David Hamer was featured on NBC 10 Boston with the latest on the omicron variant. “Preliminary data from South Africa, where omicron was first detected, indicates the strain of the virus could cause less severe symptoms, according to Boston Medical Center’s Dr. David Hamer.” Read the full article here